Seasonal Influenza Vaccines Market Forecast
Date Published:
Aug 6 Source:
Datamonitor Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new technologies and increase manufacturing capacity for influenza vaccines and antivirals. The H1N1 pandemic will stimulate further growth, but also confronts industry and public health stakeholders with new challenges.
*Review the clinical and commercial factors driving new product decisions in influenza vaccines and the strategies of key players in the market
*Size the market with patient-based scenario forecasts of the seasonal vaccines market and a thorough analysis of the vaccine and antiviral pipeline
*Understand concerns, unmet needs and future opportunities in influenza prevention and therapy
More Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
- Seasonal Influenza Vaccines Market Forecast
- Generics Series: Authorized Generics Analysis
- Pricing and Reimbursement: Innovative Risk-Sharing Strategies
- Emerging Markets Series: The Pharmaceutical Market of Poland
